To conclude, HYSA suppressed proliferation, migration, invasion, and EMT in HCT116 CRC cells by activating the PPARγ/PTEN/Akt signaling pathways, implying that HYSA may be a promising candidate for CRC therapy. Here, AKT1 is linked to colorectal carcinoma.